Recommended Topic Related To:


"The U.S. Food and Drug Administration today announced that it has approved an amended application submitted by Teva Women's Health, Inc. to market Plan B One-Step (active ingredient levonorgestrel) for use without a prescription by women 15 years"...




Overdosage of estrogen plus progestin therapy may cause nausea and vomiting, breast tenderness, dizziness, abdominal pain, drowsiness/fatigue and withdrawal bleeding may occur in women. Treatment of overdose consists of discontinuation of CE/MPA together with institution of appropriate symptomatic care.


PROVERA (medroxyprogesterone acetate tablets) should not be used in women with any of the following conditions:

  1. Undiagnosed abnormal genital bleeding
  2. Known, suspected, or history of cancer of the breast
  3. Known or suspected estrogen- or progesterone-dependent neoplasia
  4. Active deep vein thrombosis, pulmonary embolism or a history of these conditions
  5. Active or recent (within the past year) arterial thromboembolic disease (for example, stroke and myocardial infarction)
  6. Known liver dysfunction or disease
  7. Missed abortion
  8. As a diagnostic test for pregnancy
  9. Known hypersensitivity to the ingredients in PROVERA (medroxyprogesterone acetate tablets) tablets
  10. Known or suspected pregnancy.

Last reviewed on RxList: 4/9/2008
This monograph has been modified to include the generic and brand name in many instances.


Provera - User Reviews

Provera User Reviews

Now you can gain knowledge and insight about a drug treatment with Patient Discussions.

Here is a collection of user reviews for the medication Provera sorted by most helpful. Patient Discussions FAQs

Report Problems to the Food and Drug Administration


You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Women's Health

Find out what women really need.